Just read the FDA 10 page document. It seems the only concerns they raise are around manufacturing standards, maintaining efficacy and safety, and what the company has chosen as product attributes or characteristics to ensure the aforementioned are upheld, and is that measure enough. So far as the efficacy of the trials, I think it's a goer?
MSB Trading - Aug 2020 on, page-547
-
- There are more pages in this discussion • 1,838 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.010(0.85%) |
Mkt cap ! $1.353B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $4.029M | 3.402M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 29550 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 28250 | 15 |
View Market Depth
| Last trade - 14.53pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |